Compositions for treatment of melanoma and method of using same
US7556805B2 · kind B2 · utility
2Cited by
6References
10Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Nov 27, 2001 |
| Grant date | Jul 7, 2009 |
| Priority date | — |
| Expiry date | Dec 5, 2025 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K39/001191
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Melanoma can be treated in a mammalian subject by administering to the subject an immunologically-effective amount of a xenogeneic melanoma-associated differentiation antigen. For example, genetic immunization with a plasmid containing a sequence encoding human gp75 has been shown to be effective in treatment of dogs with melanoma.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.